(Q39643100)

13 September 2017

title

The effect of epigenetic regulation of fucosylation on TRAIL-induced apoptosis (English)

1 reference

13 September 2017

Kenta Moriwaki

1

1 reference

13 September 2017

Megumi Narisada

2

1 reference

13 September 2017

Taku Imai

3

1 reference

13 September 2017

Shinichiro Shinzaki

4

1 reference

13 September 2017

Eiji Miyoshi

5

1 reference

13 September 2017

language of work or name

1 reference

16 October 2010

1 reference

13 September 2017

published in

Glycoconjugate Journal

1 reference

13 September 2017

volume

27

1 reference

13 September 2017

issue

7-9

1 reference

13 September 2017

page(s)

649-659

1 reference

Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants--Hakomori's concepts revisited

13 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10719-010-9310-5

Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10719-010-9310-5

Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.

21 January 2018

1 reference

12 December 2020

DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer

1 reference

12 December 2020

Alpha-1 fetoglobulin in the diagnosis of human hepatoma

1 reference

12 December 2020

Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus

1 reference

12 December 2020

Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells

1 reference

12 December 2020

5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8.

1 reference

12 December 2020

The epigenomics of cancer

1 reference

12 December 2020

Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation.

1 reference

12 December 2020

To kill a tumor cell: the potential of proapoptotic receptor agonists

1 reference

12 December 2020

Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer

1 reference

12 December 2020

Molecular cloning of human GDP-mannose 4,6-dehydratase and reconstitution of GDP-fucose biosynthesis in vitro

1 reference

12 December 2020

Directing cancer cells to self-destruct with pro-apoptotic receptor agonists

1 reference

12 December 2020

Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells

1 reference

12 December 2020

Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens.

1 reference

12 December 2020

Synthesis of GDP-L-fucose by the human FX protein

1 reference

12 December 2020

Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer

1 reference

12 December 2020

Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.

1 reference

12 December 2020

Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling.

1 reference

12 December 2020

Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines.

1 reference

12 December 2020

Preferential response of cancer cells to zebularine.

1 reference

12 December 2020

Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines

1 reference

12 December 2020

Glycosylation in cellular mechanisms of health and disease

1 reference

12 December 2020

Molecular cloning and expression of GDP-D-mannose-4,6-dehydratase, a key enzyme for fucose metabolism defective in Lec13 cells

1 reference

12 December 2020

Medical devices; immunology and microbiology devices; classification of AFP-L3% immunological test systems. Final rule.

1 reference

12 December 2020

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

1 reference

12 December 2020

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

12 December 2020

Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

1 reference

12 December 2020

Gene silencing in cancer in association with promoter hypermethylation

1 reference

12 December 2020

The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter

1 reference

12 December 2020

The TRAIL apoptotic pathway in cancer onset, progression and therapy

1 reference

12 December 2020

Role of glycosylation in development

1 reference

12 December 2020

Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency

1 reference

12 December 2020

Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas

1 reference

12 December 2020

Biological function of fucosylation in cancer biology

1 reference

12 December 2020

A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation

1 reference

12 December 2020

Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.

1 reference

12 December 2020

Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S10719-010-9310-5

Identifiers

DOI

1 reference

13 September 2017

1 reference